Infomarket

News

Data about the Activity of Moldovan Commercial Banks on July 31, 2025Dr. Sándor Csány: Being the 4th largest, OTP in Moldova will grow both organically as well as through possible mergers and acquisitions It seems to be a place, but it is notScott HOCKLANDER: For me, the persistence of Moldovan citizens is not only a learned lesson, but also a great exampleSorin MASLO: "The year 2022 was a turning point for the "Cricova" Wine Combine, the turnover increased by almost 25%"Deposit rates are at their peak. Market conjuncture or Why banks need individuals’ depositsValeriu LAZĂR: "If the state does not support business today, tomorrow it will have no one to collect taxes from.Chisinau Airport as a reflection of statehoodMonetary measures against non-monetary inflationBanks as the fulcrum of the economy: they have increased profits and are preparing for the challenges of the 2H 2022The Ministry of Finance and investors in the State Securities market at the peak of placement volumesThe banking market: turmoil and increased demand. No panicIs Moldova ready for the economic consequences of the war in the neighboring country?Are we heading for hyperinflation? It all depends on the correct diagnosis and the prescribed treatmentWhat is happening in the Government Securities Market and what does the National Bank have to do with it?The wine industry is on the verge of a revolution: Is the industry-specific law bankrupting enterprises? The trap for the oil products marketLászló DIÓSI: Foreign investments come to Moldova due to banking system stabilityWhen there is no program with the IMF, we issue are government securities ...Nikolay BORISSOV: “Acquisition of Moldindconbank is the best procurement in the Moldovan market, albeit the most risky one”Oil Ping Pong GamesBanking 2020 - pandemic, profitableWeird 2020: humility, depression, rebellion, accepting a new realityThe Hunger Games of the foreign exchange marketHow to tame liquidity?Veaceslav IONITA: The government killed the business, but flirted with the populationPeople and Business: Natural and Unnatural SelectionAlexandru BURDEINII: Being ethical becomes vital in business nowadaysMoldova’s Key Macroeconomic IndicatorsPrices at filling stations

Luxfarmol (Tvardita) enters the US sanitizer market.

Luxfarmol (Tvardita) enters the US sanitizer market.

Semen Dyulger, Luxfarmol CEO, told InfoMarket that the USA Food and Drug Administration has granted a registration certificate for the Tvardita disinfectant, allowing it to be sold throughout the United States. The first export consignment consisted of 240 thousand single sanitizer doses. It is the first and only Moldovan sanitizer that has been approved for sale on the American market. Monodose-sanitizer is intended for individual single use and contains 3 ml of hand sanitizer (dose recommended by WHO). Such a product is in demand by airlines, restaurants, hotels, beauty salons, gas stations, etc. According to Semen Dyulger, Luxfarmol has already signed contracts for the supply of monodose sanitizer with the Belarusian Belavia (Белавиа), as well as with the Romanian and Italian carriers. Negotiations are also underway with representatives of Turkish Airlines and Russian Aeroflot (Аэрофлот). Luxfarmol has been operating since 2008 and is a resident of the Tvardita Free Economic Zone. Since 2011, the company has been producing disinfectants. Prior to the pandemic, Luxfarmol production volumes were about 40 tons per year, half of which was exported to Ukraine. In the domestic market, the goods were supplied mainly to medical institutions, to customs and border checkpoints, as well as for the needs of the army and police units. The sales volume of Luxfarmol increased significantly during the pandemic: if in 2018 sales reached 4.7 million lei, and in 2019 - 1.2 million lei, then in 2020 the sales volume of Luxfarmol reached 55 million lei, and the production profitability was about 20%. Last year, the company expanded its range of antiseptics in various dosages: antibacterial gel and monodose gel appeared in the production line. Luxfarmol products are registered in Russia, Belarus, Ukraine, Italy, Great Britain and the USA, and the company continues to invest in promoting its products in Western markets. It is investing as well in laboratory research to obtain local certifications. The total investment of Luxfarmol is estimated at $2 million // 30.04.2021 – InfoMarket